These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

601 related articles for article (PubMed ID: 34387645)

  • 1. Variants of SARS-CoV-2.
    Lauring AS; Malani PN
    JAMA; 2021 Aug; ():. PubMed ID: 34387645
    [No Abstract]   [Full Text] [Related]  

  • 2. The global epidemic of SARS-CoV-2 variants and their mutational immune escape.
    Tian D; Sun Y; Zhou J; Ye Q
    J Med Virol; 2022 Mar; 94(3):847-857. PubMed ID: 34609003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variants.
    Wirnsberger G; Monteil V; Eaton B; Postnikova E; Murphy M; Braunsfeld B; Crozier I; Kricek F; Niederhöfer J; Schwarzböck A; Breid H; Jimenez AS; Bugajska-Schretter A; Dohnal A; Ruf C; Gugenberger R; Hagelkruys A; Montserrat N; Holbrook MR; Oostenbrink C; Shoemaker RH; Mirazimi A; Penninger JM
    bioRxiv; 2021 Sep; ():. PubMed ID: 34545368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology and Characteristics of SARS-CoV-2 Variants of Concern: The Impacts of the Spike Mutations.
    Cocherie T; Zafilaza K; Leducq V; Marot S; Calvez V; Marcelin AG; Todesco E
    Microorganisms; 2022 Dec; 11(1):. PubMed ID: 36677322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variants.
    Monteil V; Eaton B; Postnikova E; Murphy M; Braunsfeld B; Crozier I; Kricek F; Niederhöfer J; Schwarzböck A; Breid H; Devignot S; Klingström J; Thålin C; Kellner MJ; Christ W; Havervall S; Mereiter S; Knapp S; Sanchez Jimenez A; Bugajska-Schretter A; Dohnal A; Ruf C; Gugenberger R; Hagelkruys A; Montserrat N; Kozieradzki I; Hasan Ali O; Stadlmann J; Holbrook MR; Schmaljohn C; Oostenbrink C; Shoemaker RH; Mirazimi A; Wirnsberger G; Penninger JM
    EMBO Mol Med; 2022 Aug; 14(8):e15230. PubMed ID: 35781796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diverse vaccine platforms safeguarding against SARS-CoV-2 and its variants.
    Chatterjee B; Thakur SS
    Expert Rev Vaccines; 2022 Jan; 21(1):47-67. PubMed ID: 34697980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of SARS-CoV-2 variants requires urgent global coordination.
    Duarte CM; Jamil T; Gojobori T; Alam I
    Int J Infect Dis; 2021 Aug; 109():50-53. PubMed ID: 34147667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High number of seizures and unconsciousness in patients with SARS-CoV-2 omicron variants: a retrospective study.
    Tokuyama K; Kitamura T; Maruyama K; Toriumi S; Murano Y; Yoneoka D; Nakazawa T; Shimizu T
    Front Pediatr; 2023; 11():1273464. PubMed ID: 38034823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detecting SARS-CoV-2 BA.2, BA.4, and BA.5 Variants Utilizing a Robust RT-RPA-CRISPR/Cas12a-Based Method - China, 2023.
    Luo M; Pan Y; He Y; A R; Wu C; Huang B; Lu R; Zhao L; Peng B; Ye F; Wang H; Chen Y; Li Z; Zhang D; Wang W; Tan W
    China CDC Wkly; 2023 Jun; 5(26):584-591. PubMed ID: 37457851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-precision rapid testing of omicron SARS-CoV-2 variants in clinical samples using AI-nanopore.
    Murakami K; Kubota SI; Tanaka K; Tanaka H; Akabane K; Suzuki R; Shinohara Y; Takei H; Hashimoto S; Tanaka Y; Hojyo S; Sakamoto O; Naono N; Takaai T; Sato K; Kojima Y; Harada T; Hattori T; Fuke S; Yokota I; Konno S; Washio T; Fukuhara T; Teshima T; Taniguchi M; Murakami M
    Lab Chip; 2023 Nov; 23(22):4909-4918. PubMed ID: 37877206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanotechnology-based strategies against SARS-CoV-2 variants.
    Huang X; Kon E; Han X; Zhang X; Kong N; Mitchell MJ; Peer D; Tao W
    Nat Nanotechnol; 2022 Oct; 17(10):1027-1037. PubMed ID: 35982317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and circulation patterns of SARS-CoV-2 variants in European sewage mirror clinical data of 54 European cities.
    Agrawal S; Orschler L; Schubert S; Zachmann K; Heijnen L; Tavazzi S; Gawlik BM; de Graaf M; Medema G; Lackner S
    Water Res; 2022 May; 214():118162. PubMed ID: 35193077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Comprehensive Review on the Current Vaccines and Their Efficacies to Combat SARS-CoV-2 Variants.
    Rabaan AA; Mutair AA; Hajissa K; Alfaraj AH; Al-Jishi JM; Alhajri M; Alwarthan S; Alsuliman SA; Al-Najjar AH; Al Zaydani IA; Al-Absi GH; Alshaikh SA; Alkathlan MS; Almuthree SA; Alawfi A; Alshengeti A; Almubarak FZ; Qashgari MS; Abdalla ANK; Alhumaid S
    Vaccines (Basel); 2022 Oct; 10(10):. PubMed ID: 36298520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly Sensitive Detection Method for HV69-70del in SARS-CoV-2 Alpha and Omicron Variants Based on CRISPR/Cas13a.
    Niu M; Han Y; Dong X; Yang L; Li F; Zhang Y; Hu Q; Xia X; Li H; Sun Y
    Front Bioeng Biotechnol; 2022; 10():831332. PubMed ID: 35497364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 Variants, Current Vaccines and Therapeutic Implications for COVID-19.
    Liang HY; Wu Y; Yau V; Yin HX; Lowe S; Bentley R; Ahmed MA; Zhao W; Sun C
    Vaccines (Basel); 2022 Sep; 10(9):. PubMed ID: 36146616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 Variants in Rhode Island; May 2022 Update.
    Singh M; Novitsky V; Carpenter-Azevedo K; Howison M; Huard RC; King E; Kantor R
    R I Med J (2013); 2022 Aug; 105(6):6-11. PubMed ID: 35834172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coinfections with SARS-CoV-2 variants and influenza virus during the 2019 Coronavirus disease pandemic in Burkina Faso: A surveillance study.
    Lingani M; Cissé A; Tialla D; Ilboudo AK; Savadogo M; Sawadogo C; Gampini S; Tarnagda G; Tao M; Diagbouga S; Bamba S; Tarnagda Z
    Health Sci Rep; 2023 Jan; 6(1):e1041. PubMed ID: 36620510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of SARS-CoV-2 Variants From 24,181 Patients Exemplifies the Role of Globalization and Zoonosis in Pandemics.
    Colson P; Fournier PE; Chaudet H; Delerce J; Giraud-Gatineau A; Houhamdi L; Andrieu C; Brechard L; Bedotto M; Prudent E; Gazin C; Beye M; Burel E; Dudouet P; Tissot-Dupont H; Gautret P; Lagier JC; Million M; Brouqui P; Parola P; Fenollar F; Drancourt M; La Scola B; Levasseur A; Raoult D
    Front Microbiol; 2021; 12():786233. PubMed ID: 35197938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Disease Severity and Clinical Outcomes of the SARS-CoV-2 Variants of Concern.
    Lin L; Liu Y; Tang X; He D
    Front Public Health; 2021; 9():775224. PubMed ID: 34917580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid identification of SARS-CoV-2 variants: Validation of the simplexa SARS-CoV-2 variant direct assay.
    Eptaminitaki GC; Parakatselaki ME; Petroulaki C; Marinopoulou D; Pitsikaki A; Tseliou M; Zafiropoulos A; Sourvinos G
    J Virol Methods; 2023 Sep; 319():114759. PubMed ID: 37257757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.